About the Authors
- Vijay Ramakrishnan
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- Teresa Kimlinger
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- Jessica Haug
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- Utkarsh Painuly
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- Linda Wellik
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- Timothy Halling
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- S. Vincent Rajkumar
-
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
- Shaji Kumar
-
* E-mail: kumar.shaji@mayo.edu
Affiliation The Divisions of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America
Competing Interests
SK received research support from Celgene, Millennium, Novartis, Merck, Cephalon, Genzyme and Bayer. SK is on the advisory board of Merck. MK-2206 was provided by Merck. & Co., Inc. (Whitehouse Station, NJ). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: VR SVR SK. Performed the experiments: VR TK JH UP LW TH. Analyzed the data: VR SVR SK. Contributed reagents/materials/analysis tools: SVR SK. Wrote the paper: VR SVR SK.